ROLE OF NON-INVASIVE LEFT VENTRICULAR PRESSURE-STRAIN LOOP TO PREDICT CARDIAC DEATH AND ARRHYTHMIC RISK IN PATIENT WITH ORGANIC HEART DISEASE AND REDUCED LEFT VENTRICULAR EJECTION FRACTION

2019 ◽  
Vol 73 (9) ◽  
pp. 1625
Author(s):  
Marco Previtero ◽  
Danila Azzolina ◽  
Chiara Palermo ◽  
Rosaria M. Tenaglia ◽  
Giuseppe Sammarco ◽  
...  
1988 ◽  
Vol 27 (02) ◽  
pp. 57-62
Author(s):  
R. Standke ◽  
R. P. Baum ◽  
S. Tezak ◽  
D. Mildenberger ◽  
F. D. Maul ◽  
...  

21 patients with LAD-stenoses of at least 70% and 21 patients with LAD- stenoses and additional intramural anterior wall infarctions were studied. 20 patients without heart disease or after successful transluminal coronary angioplasty and 18 patients with intramural anterior wall infarction after successful transluminal dilatation of the LAD (remaining stenosis maximal 30%) served as controls. The normal range of global and regional left ventricular ejection fraction response to exercise was defined based on the data of 25 further patients without relevant coronary heart disease. Thus, a decrease in global ejection fraction and regional wall motion abnormalities were judged pathological. All patients were comparable with respect to age, ejection fraction at rest and work load. Myocardial ischemia could be detected by the exercise ECG in 81 % of all patients without infarction and in 71 % of patients with infarction. The corresponding values for global left ventricular ejection fraction were 76% and 81 %, respectively, and for regional ejection fraction 95% in both groups. No false-positive exercise ECGs were observed in the healthy controls and 2 (11 %) in the corresponding group with intramural infarction. The global ejection fraction was pathological in 1 (5%) healthy subject without infarction and in 3 (17%) corresponding patients with infarction. Sectorial analysis revealed 5 and 22%, respectively. Our findings suggest that the exercise ECG has a limited sensitivity to detect myocardial ischemia in patients with isolated LAD-stenoses and intramural myocardial infarction. Radionuclide ventriculography yields pathological values more often; however, false-positive results also occur more frequently.


1977 ◽  
Vol 53 (1) ◽  
pp. 55-61 ◽  
Author(s):  
A. L. Muir ◽  
W. J. Hannan ◽  
H. M. Brash ◽  
V. Baldwa ◽  
H. C. Miller ◽  
...  

1. In 18 patients with ischaemic heart disease left ventricular ejection fraction, measured by two different nuclear angiographic methods, has been compared with ejection fraction measured by single-plane contrast angiography. 2. The first nuclear angiographic technique involves detection of variation in the radioactivity from the left ventricle during the initial passage of a bolus of 99Tcm-labelled human serum albumin injected intravenously; the second is our own modification of a ‘gated’ method, which accumulates the radioactivity detected during the continuing recirculation of the plasma bound radioisotope, so presenting an ‘averaged’ ventricular volume curve. 3. Ejection fraction, measured by the ‘bolus’ method, is lower than that measured either by contrast ventriculography or by the ‘gated’ method. This may be due to a damping effect. 4. Ejection fraction measured by the ‘gated’ method is well correlated with that measured by contrast ventriculography (r = 0·89). 5. Our modification of the ‘gated’ method, which presents the changes in ventricular volume throughout the cardiac cycle, without needing computer facilities, is a useful non-invasive means for assessment of left ventricular function.


ESC CardioMed ◽  
2018 ◽  
pp. 2327-2330
Author(s):  
Juan Fernandez-Armenta ◽  
Antonio Berruezo ◽  
Juan Acosta ◽  
Diego Penela

Risk stratification for sudden cardiac death (SCD) is one of the main objectives of clinical arrhythmology. Despite increased knowledge of the fundamental basis and predictors of SCD, the estimation of individual risk remains challenging. To date, symptomatic heart failure and reduced left ventricular ejection fraction are the main variables used to identify patients at high risk of SCD who could potentially benefit from preventive therapies. Beyond left ventricular ejection fraction, new diagnostic tools have been proposed to better stratify patients at risk of SCD. Among them, cardiovascular magnetic resonance imaging, which allows direct visualization of the arrhythmogenic substrate, is considered particularly promising. Genetic testing and serum biomarkers may also have a role in SCD risk assessment.


Sign in / Sign up

Export Citation Format

Share Document